EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeted degradation of BRD4 by PROTACs: advances in cancer therapy

Yanyun Hong, Xiang Liu, Yinglong Li, Mengting Yu, Caolin Wang, Cunpeng Nie, Shan Xu

Chemical Communications · 2026 · 62 (17) · 4869-4888

DOI: 10.1039/d5cc05563f ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemical Communications, 2026. Verfasst von Yanyun Hong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 33001…. Hauptthemen laut MEDLINE: Neoplasms, Transcription Factors, Cell Cycle Proteins, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 145 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangxi Province, Jiangxi Science and Technology Normal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This schematic illustrates the multidimensional optimization strategies for BRD4-targeting PROTACs, encompassing the rational design of the ternary complex, diverse controllable activation systems, and targeted delivery approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsTranscription FactorsCell Cycle ProteinsAntineoplastic AgentsHumansBromodomain Containing ProteinsProteolysis Targeting ChimeraProteolysisAnimals

Substanzen

Bromodomain Containing ProteinsProteolysis Targeting ChimeraBRD4 protein, humanTranscription FactorsCell Cycle ProteinsAntineoplastic Agents

Autor:innen und Institutionen

  • Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013, Jiangxi, China. shanxu9891@126.com.
  • East China University of Science and Technology, Shanghai, China.

Förderung

  • Natural Science Foundation of Jiangxi Province
  • Jiangxi Science and Technology Normal University

Zitieren

APA

Hong, Y., Liu, X., Li, Y., Yu, M., Wang, C., Nie, C., & Xu, S. (2026). Targeted degradation of BRD4 by PROTACs: advances in cancer therapy. Chemical Communications, 62(17), 4869-4888. https://doi.org/10.1039/d5cc05563f

Vancouver

Hong Y, Liu X, Li Y, Yu M, Wang C, Nie C, et al. Targeted degradation of BRD4 by PROTACs: advances in cancer therapy. Chemical Communications. 2026;62(17):4869-4888. doi:10.1039/d5cc05563f

BibTeX
@article{Hong2026,
  author = {Hong, Yanyun and Liu, Xiang and Li, Yinglong and Yu, Mengting and Wang, Caolin and Nie, Cunpeng and Xu, Shan},
  title = {Targeted degradation of BRD4 by PROTACs: advances in cancer therapy},
  journal = {Chemical Communications},
  year = {2026},
  volume = {62},
  number = {17},
  pages = {4869--4888},
  doi = {10.1039/d5cc05563f}
}
Kostenlos starten →